New Insights into the Mechanisms of Nonimmune Thrombocytopenia in Neonates

Seminars in Perinatology

Volumn 33, Issue 1, 2009, Pages 43-51

  Sola Visner, Martha ^a   Sallmon, Hannes ^a,b   Brown, Rachel ^c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^c NATIONWIDE CHILDREN S HOSPITAL   (United States)

Author keywords

intrauterine hypoxia; megakaryocytopoiesis; necrotizing enterocolitis; neonate; sepsis; thrombocytopenia

Indexed keywords

GLYCOCALICIN; PLATELET DERIVED GROWTH FACTOR; THROMBOPOIETIN;

BONE MARROW; CYTOMEGALOVIRUS INFECTION; ENTEROVIRUS INFECTION; FETUS HYPOXIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MEGAKARYOCYTE; MEGAKARYOPOIESIS; NECROTIZING ENTEROCOLITIS; NEONATAL THROMBOCYTOPENIA; NEWBORN; NEWBORN INTENSIVE CARE; PRIORITY JOURNAL; REVIEW; SEPSIS; THROMBOCYTOPOIESIS;

HUMANS; INFANT, NEWBORN; PLATELET COUNT; THROMBOCYTOPENIA; THROMBOPOIESIS; THROMBOPOIETIN;

EID: 58249142101     PISSN: 01460005     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semperi.2008.10.008     Document Type: Review

References (72)

1. Debili N., Wendling F., Katz A., et al. The Mpl-ligand or thrombopoietin or megakaryocyte growth and differentiative factor has both direct proliferative and differentiative activities on human megakaryocyte progenitors. Blood 86 (1995) 2516-2525
2. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 115 (2005) 3339-3347
3. Kaushansky K. Historical review: Megakaryopoiesis and thrombopoiesis. Blood 111 (2008) 981-986
4. Junt T., Schulze H., Chen Z., et al. Dynamic visualization of thrombopoiesis within bone marrow. Science 317 (2007) 1767-1770
5. Patel S.R., Hartwig J.H., and Italiano Jr. J.E. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115 (2005) 3348-3354
6. Richardson J.L., Shivdasani R.A., Boers C., et al. Mechanisms of organelle transport and capture along proplatelets during platelet production. Blood 106 (2005) 4066-4075
7. Sola M.C., Juul S.E., Meng Y.G., et al. Thrombopoietin (Tpo) in the fetus and neonate: Tpo concentrations in preterm and term neonates, and organ distribution of Tpo and its receptor (c-mpl) during human fetal development. Early Hum Dev 53 (1999) 239-250
8. Dame C. Developmental biology of thrombopoietin in the human fetus and neonate. Acta Paediatr Suppl 91 (2002) 54-65
9. Murray N.A., Watts T.L., and Roberts I.A. Endogenous thrombopoietin levels and effect of recombinant human thrombopoietin on megakaryocyte precursors in term and preterm babies. Pediatr Res 43 (1998) 148-151
10. Sola M.C., Calhoun D.A., Hutson A.D., et al. Plasma thrombopoietin concentrations in thrombocytopenic and non-thrombocytopenic patients in a neonatal intensive care unit. Br J Haematol 104 (1999) 90-92
11. Nishihira H., Toyoda Y., Miyazaki H., et al. Growth of macroscopic human megakaryocyte colonies from cord blood in culture with recombinant human thrombopoietin (c-mpl ligand) and the effects of gestational age on frequency of colonies. Br J Haematol 92 (1996) 23-28
12. Sola M.C., Du Y., Hutson A.D., et al. Dose-response relationship of megakaryocyte progenitors from the bone marrow of thrombocytopenic and non-thrombocytopenic neonates to recombinant thrombopoietin. Br J Haematol 110 (2000) 449-453
13. Olson T.A., Levine R.F., Mazur E.M., et al. Megakaryocytes and megakaryocyte progenitors in human cord blood. Am J Pediatr Hematol Oncol 14 (1992) 241-247
14. Levine R.F., Olson T.A., Shoff P.K., et al. Mature micromegakaryocytes: An unusual developmental pattern in term infants. Br J Haematol 94 (1996) 391-399
15. Mattia G., Vulcano F., Milazzo L., et al. Different ploidy levels of megakaryocytes generated from peripheral or cord blood CD34+ cells are correlated with different levels of platelet release. Blood 99 (2002) 888-897
16. Harker L.A., and Finch C.A. Thrombokinetics in man. J Clin Invest 48 (1969) 963-974
17. Sola-Visner M.C., Christensen R.D., Hutson A.D., et al. Megakaryocyte size and concentration in the bone marrow of thrombocytopenic and nonthrombocytopenic neonates. Pediatr Res 61 (2007) 479-484
18. Slayton W.B., Wainman D.A., Li X.M., et al. Developmental differences in megakaryocyte maturation are determined by the microenvironment. Stem Cells 23 (2005) 1400-1408
19. Ignatz M., Sola-Visner M., Rimsza L.M., et al. Umbilical cord blood produces small megakaryocytes after transplantation. Biol Blood Marrow Transplant 13 (2007) 145-150
20. Pastos K.M., Slayton W.B., Rimsza L.M., et al. Differential effects of recombinant thrombopoietin and bone marrow stromal-conditioned media on neonatal versus adult megakaryocytes. Blood 108 (2006) 3360-3362
21. Emmons R.V., Reid D.M., Cohen R.L., et al. Human thrombopoietin levels are high when thrombocytopenia is due to megakaryocyte deficiency and low when due to increased platelet destruction. Blood 87 (1996) 4068-4071
22. Peck-Radosavljevic M., Wichlas M., Zacherl J., et al. Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood 95 (2000) 795-801
23. Dame C. Thrombopoietin in thrombocytopenias of childhood. Semin Thromb Hemost 27 (2001) 215-228
24. Murray N.A., and Roberts I.A. Circulating megakaryocytes and their progenitors (BFU-MK and CFU-MK) in term and pre-term neonates. Br J Haematol 89 (1995) 41-46
25. Murray N.A., and Roberts I.A. Circulating megakaryocytes and their progenitors in early thrombocytopenia in preterm neonates. Pediatr Res 40 (1996) 112-119
26. Saxonhouse M.A., Christensen R.D., Walker D.M., et al. The concentration of circulating megakaryocyte progenitors in preterm neonates is a function of post-conceptional age. Early Hum Dev 78 (2004) 119-124
27. Ault K.A. Flow cytometric measurement of platelet function and reticulated platelets. Ann NY Acad Sci 677 (1993) 293-308
28. Ault K.A., Rinder H.M., Mitchell J., et al. The significance of platelets with increased RNA content (reticulated platelets). A measure of the rate of thrombopoiesis. Am J Clin Pathol 98 (1992) 637-646
29. Joseph M.A., Adams D., Maragos J., et al. Flow cytometry of neonatal platelet RNA. J Pediatr Hematol Oncol 18 (1996) 277-281
30. Peterec S.M., Brennan S.A., Rinder H.M., et al. Reticulated platelet values in normal and thrombocytopenic neonates. J Pediatr 129 (1996) 269-274
31. Jilma-Stohlawetz P., Homoncik M., Jilma B., et al. High levels of reticulated platelets and thrombopoietin characterize fetal thrombopoiesis. Br J Haematol 112 (2001) 466-468
32. Saxonhouse M.A., Sola M.C., Pastos K.M., et al. Reticulated platelet percentages in term and preterm neonates. J Pediatr Hematol Oncol 26 (2004) 797-802
33. Briggs C., Hart D., Kunka S., et al. Immature platelet fraction measurement: a future guide to platelet transfusion requirement after haematopoietic stem cell transplantation. Transfus Med 16 (2006) 101-109
34. Briggs C., Kunka S., Hart D., et al. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 126 (2004) 93-99
35. Abe Y., Wada H., Tomatsu H., et al. A simple technique to determine thrombopoiesis level using immature platelet fraction (IPF). Thromb Res 118 (2006) 463-469
36. Saigo K., Sakota Y., Masuda Y., et al. Automatic detection of immature platelets for decision making regarding platelet transfusion indications for pediatric patients. Transfus Apher Sci 38 (2008) 127-132
37. Cremer M., Paetzold J., Schmalisch G., et al. Immature platelet fraction as novel laboratory parameter predicting the course of neonatal thrombocytopenia. Br J Haematol (2008) (in press)
38. Robinson M., Machin S., Mackie I., et al. Comparison of glycocalicin, thrombopoietin and reticulated platelet measurement as markers of platelet turnover in HIV+ samples. Platelets 12 (2001) 108-113
39. van den Oudenrijn S., Bruin M., Folman C.C., et al. Three parameters, plasma thrombopoietin levels, plasma glycocalicin levels and megakaryocyte culture, distinguish between different causes of congenital thrombocytopenia. Br J Haematol 117 (2002) 390-398
40. Fabris F., Cordiano I., Steffan A., et al. Indirect study of thrombopoiesis (TPO, reticulated platelets, glycocalicin) in patients with hereditary macrothrombocytopenia. Eur J Haematol 64 (2000) 151-156
41. Koike Y., Yoneyama A., Shirai J., et al. Evaluation of thrombopoiesis in thrombocytopenic disorders by simultaneous measurement of reticulated platelets of whole blood and serum thrombopoietin concentrations. Thromb Haemost 79 (1998) 1106-1110
42. Kurata Y., Hayashi S., Kiyoi T., et al. Diagnostic value of tests for reticulated platelets, plasma glycocalicin, and thrombopoietin levels for discriminating between hyperdestructive and hypoplastic thrombocytopenia. Am J Clin Pathol 115 (2001) 656-664
43. Sola M.C., Rimsza L.M., and Christensen R.D. A bone marrow biopsy technique suitable for use in neonates. Br J Haematol 107 (1999) 458-460
44. Murray N.A. Evaluation and treatment of thrombocytopenia in the neonatal intensive care unit. Acta Paediatr Suppl 91 (2002) 74-81
45. Roberts I.A., and Murray N.A. Thrombocytopenia in the newborn. Curr Opin Pediatr 15 (2003) 17-23
46. Watts T.L., Murray N.A., and Roberts I.A. Thrombopoietin has a primary role in the regulation of platelet production in preterm babies. Pediatr Res 46 (1999) 28-32
47. Meberg A. Transitory thrombocytopenia in newborn mice after intrauterine hypoxia. Pediatr Res 14 (1980) 1071-1073
48. McDonald T.P., Cottrell M.B., Steward S.A., et al. Comparison of platelet production in two strains of mice with different modal megakaryocyte DNA ploidies after exposure to hypoxia. Exp Hematol 20 (1992) 51-56
49. Fandrey J. Oxygen-dependent and tissue-specific regulation of erythropoietin gene expression. Am J Physiol 286 (2004) R977-R988
50. McDonald T.P., Clift R.E., and Cottrell M.B. Large, chronic doses of erythropoietin cause thrombocytopenia in mice. Blood 80 (1992) 352-358
51. Ohls R.K., Ehrenkranz R.A., Wright L.L., et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: A multicenter, randomized, controlled trial. Pediatrics 108 (2001) 934-942
52. Maier R.F., Obladen M., Muller-Hansen I., et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 141 (2002) 8-15
53. Papayannopoulou T., Brice M., Farrer D., et al. Insights into the cellular mechanisms of erythropoietin-thrombopoietin synergy. Exp Hematol 24 (1996) 660-669
54. Saxonhouse M.A., Rimsza L.M., Stevens G., et al. Effects of hypoxia on megakaryocyte progenitors obtained from the umbilical cord blood of term and preterm neonates. Biol Neonate 89 (2006) 104-108
55. Colarizi P., Fiorucci P., Caradonna A., et al. Circulating thrombopoietin levels in neonates with infection. Acta Paediatr 88 (1999) 332-337
56. Brown R.E., Rimsza L.M., Pastos K., et al. Effects of sepsis on neonatal thrombopoiesis. Pediatr Res (2008) [Epub ahead of print]
57. Lambert M.P., Rauova L., Bailey M., et al. Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: Clinical and therapeutic implications. Blood 110 (2007) 1153-1160
58. Scaradavou A. HIV-related thrombocytopenia. Blood Rev 16 (2002) 73-76
59. Roux W., Pieper C., and Cotton M. Thrombocytopoenia as marker for HIV exposure in the neonate. J Trop Pediatr 47 (2001) 208-210
60. Nardi M., Tomlinson S., Greco M.A., et al. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell 106 (2001) 551-561
61. Cole J.L., Marzec U.M., Gunthel C.J., et al. Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood 91 (1998) 3239-3246
62. Sato T., Sekine H., Kakuda H., et al. HIV infection of megakaryocytic cell lines. Leuk Lymphoma 36 (2000) 397-404
63. Rozmyslowicz T., Majka M., Kijowski J., et al. Platelet- and megakaryocyte-derived microparticles transfer CXCR4 receptor to CXCR4-null cells and make them susceptible to infection by X4-HIV. AIDS 17 (2003) 33-42
64. Tighe P., Rimsza L.M., Christensen R.D., et al. Severe thrombocytopenia in a neonate with congenital HIV infection. J Pediatr 146 (2005) 408-413
65. Fowler K.B., Stagno S., and Pass R.F. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis 168 (1993) 552-556
66. Boppana S.B., Pass R.F., Britt W.J., et al. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 11 (1992) 93-99
67. Kylat R.I., Kelly E.N., and Ford-Jones E.L. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. Eur J Pediatr 165 (2006) 773-778
68. Aslam M., Anderson J.L., Guglietti D., et al. CMV-induced neonatal thrombocytopenia: A case report and review of the literature. Am J Perinatol 24 (2007) 429-434
69. Muller A., Eis-Hubinger A.M., Brandhorst G., et al. Oral valganciclovir for symptomatic congenital cytomegalovirus infection in an extremely low birth weight infant. J Perinatol 28 (2008) 74-76
70. Steinberg H.N., Anderson Jr. J., Lim B., et al. Cytomegalovirus infection of the BS-1 human stroma cell line: Effect on murine hemopoiesis. Virology 196 (1993) 427-432
71. Abzug M.J., Levin M.J., and Rotbart H.A. Profile of enterovirus disease in the first two weeks of life. Pediatr Infect Dis J 12 (1993) 820-824
72. Cheng L.L., Ng P.C., Chan P.K., et al. Probable intrafamilial transmission of coxsackievirus b3 with vertical transmission, severe early-onset neonatal hepatitis, and prolonged viral RNA shedding. Pediatrics 118 (2006) e929-e933